Continued androgen signalling inhibition improves cabazitaxel efficacy in prostate cancer

Author:

Mout LisanneORCID,van Royen Martin E.,de Ridder Corrina,Stuurman Debra,van de Geer Wesley S.,Marques Rute,Buck Stefan A.J.ORCID,French Pim J.,van de Werken Harmen J.G.,Mathijssen Ron H.J.,de Wit Ronald,Lolkema Martijn P.,van Weerden Wytske M.

Funder

Sanofi

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference31 articles.

1. In vivo amplification of the androgen receptor gene and progression of human prostate cancer;Visakorpi;Nat Genet,1995

2. Bentel JM. Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence;Tilley;Clin Cancer Res,1996

3. The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact;van Dessel;Nature Communications,2019

4. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer;Quigley;Cell,2018

5. Cross-resistance and drug sequence in prostate cancer;Buck;Drug Resist Updat,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3